The Health Utilities Index (HUI®): concepts, measurement properties and applications

Health Utilities Inc, Dundas, ON, Canada.
Health and Quality of Life Outcomes (Impact Factor: 2.1). 02/2003; 1:54. DOI: 10.1186/1477-7525-1-54
Source: PubMed

ABSTRACT This is a review of the Health Utilities Index (HUI) multi-attribute health-status classification systems, and single- and multi-attribute utility scoring systems. HUI refers to both HUI Mark 2 (HUI2) and HUI Mark 3 (HUI3) instruments. The classification systems provide compact but comprehensive frameworks within which to describe health status. The multi-attribute utility functions provide all the information required to calculate single-summary scores of health-related quality of life (HRQL) for each health state defined by the classification systems. The use of HUI in clinical studies for a wide variety of conditions in a large number of countries is illustrated. HUI provides comprehensive, reliable, responsive and valid measures of health status and HRQL for subjects in clinical studies. Utility scores of overall HRQL for patients are also used in cost-utility and cost-effectiveness analyses. Population norm data are available from numerous large general population surveys. The widespread use of HUI facilitates the interpretation of results and permits comparisons of disease and treatment outcomes, and comparisons of long-term sequelae at the local, national and international levels.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Background. Manual wheelchairs (MWCs) can improve mobility and social participation for individuals who experience difficulty walking; however, older adults receive little training for wheelchair use. The Wheelchair Self-Efficacy Enhanced for Use (VVheelSeeU) research program provides peer-led training that may positively influence wheelchair use while reducing clinician burden. Purpose. The purpose of this study is to evaluate the feasibility and clinical outcomes of WheelSeeU. Method. A randomized control trial (RCT) recruits and randomly assigns 40 MWC users (55+ years). Feasibility indicators assessing process, resource, management, and treatment issues are measured, and clinical outcomes (wheelchair skills, safety, confidence, mobility, social participation, quality of life, health utility) are collected at three time points. Implications. WheelSeeU provides an innovative approach for teaching wheelchair skills to an aging population that may improve wheelchair use and decrease clinician burden. Since RCTs are expensive and challenging in rehabilitation, establishing feasibility prior to larger effectiveness trials is prudent.
    Canadian Journal of Occupational Therapy 12/2014; 81(5):308-319. DOI:10.1177/0008417414546743 · 0.74 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Standard gamble (SG) and time trade-off (TTO) are two methods used for obtaining health utility values (utilities). Whether the order in which the methods are applied alters the relative utilities obtained by each method is unknown.Objective We sought to determine whether the order in which SG and TTO utilities were obtained affects the relative values of the utilities obtained by each technique.Methods Utilities were assessed for 29 health states from 4016 parents by using SG and TTO. The assessment order was randomized by respondent. For analysis by health state, we calculated (SG –TTO) for each assessment and tested whether the SG – TTO difference was significantly different between the two groups (SG first and TTO first). For analysis by individual, we calculated a risk-posture coefficient, γ, defined by the utility curve, SG = TTOγ. We predicted γ through regression analysis with the covariates: child age, child sex, birth order, respondent age, respondent education level, and assessment method order.ResultsIn 19 of 29 health states, the SG − TTO difference was significantly greater (more risk averse) when TTO was assessed first. In the regression analysis, “child age” and “assessment method order” were significant predictors of risk attitude. The risk posture coefficient γ was higher (more risk-seeking) with increasing child age and in the SG-first respondents.Conclusion The order in which the SG versus TTO method is used strongly influences the relative values of the utilities obtained.
    Value in Health 09/2012; 15(6):926-932. DOI:10.1016/j.jval.2012.04.008 · 2.89 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Patients with venous thromboembolism (VTE) commonly have an underlying genetic predisposition. However, genetic tests nowadays in use have very low sensitivity for identifying subjects at risk of VTE. Thrombo inCode(®) is a new genetic tool that has demonstrated very good sensitivity, thanks to very good coverage of the genetic variants that modify the function of the coagulation pathway. To conduct an economic analysis of risk assessment of VTE from the perspective of the Spanish National Health System with Thrombo inCode(®) (a clinical-genetic function for assessing the risk of VTE) versus the conventional/standard method used to date (factor V Leiden and prothrombin G20210A). An economic model was created from the National Health System perspective, using a decision tree in patients aged 45 years with a life expectancy of 81 years. The predictive capacity of VTE, based on identification of thrombophilia using Thrombo inCode(®) and using the standard method, was obtained from two case-control studies conducted in two different populations (S. PAU and MARTHA; 1,451 patients in all). Although this is not always the case, patients who were identified as suffering from thrombophilia were subject to preventive treatment of VTE with warfarin, leading to a reduction in the number of VTE events and an increased risk of severe bleeding. The health state utilities (quality-adjusted life-years [QALYs]) and costs (in 2013 EUR values) were obtained from the literature and Spanish sources. On the basis of a price of EUR 180 for Thrombo inCode(®), this would be the dominant option (more effective and with lower costs than the standard method) in both populations. The Monte Carlo probabilistic analyses indicate that the dominance would occur in 100 % of the simulations in both populations. The threshold price of Thrombo inCode(®) needed to reach the incremental cost-effectiveness ratio (ICER) generally accepted in Spain (EUR 30,000 per QALY gained) would be between EUR 3,950 (in the MARTHA population) and EUR 11,993 (in the S. PAU population). According to the economic model, Thrombo inCode(®) is the dominant option in assessing the risk of VTE, compared with the standard method currently used.
    Applied Health Economics and Health Policy 02/2015; DOI:10.1007/s40258-015-0153-x

Full-text (3 Sources)

Available from
May 31, 2014